Protalix BioTherapeutics - 22 Year Stock Price History | PLX

Historical daily share price chart and data for Protalix BioTherapeutics since 1998 adjusted for splits. The latest closing stock price for Protalix BioTherapeutics as of March 30, 2020 is 2.38.
  • The all-time high Protalix BioTherapeutics stock closing price was 875.00 on May 18, 1998.
  • The Protalix BioTherapeutics 52-week high stock price is 5.19, which is 118.1% above the current share price.
  • The Protalix BioTherapeutics 52-week low stock price is 1.70, which is 28.6% below the current share price.
  • The average Protalix BioTherapeutics stock price for the last 52 weeks is 3.24.
Protalix BioTherapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.3221 3.5600 4.6100 2.1000 2.3800 -27.44%
2019 3.5303 3.4000 5.5000 1.7560 3.2800 5.47%
2018 5.1844 6.9390 7.5200 2.9450 3.1100 -52.96%
2017 7.8780 4.1530 14.4000 4.0500 6.6120 48.58%
2016 6.8047 10.1000 10.2000 2.8520 4.4500 -56.37%
2015 16.5446 18.7000 23.4000 7.8000 10.2000 -44.57%
2014 34.1525 39.6000 52.6000 18.0000 18.4000 -52.70%
2013 50.3766 54.0000 61.5000 37.2000 38.9000 -25.05%
2012 57.2596 50.0000 72.0000 48.0000 51.9000 5.27%
2011 64.8742 104.1000 104.6000 43.6000 49.3000 -50.60%
2010 75.6167 69.0000 100.0000 58.4000 99.8000 50.76%
2009 53.2214 18.5000 121.4000 18.0000 66.2000 259.78%
2008 25.4462 34.6000 37.0000 9.6000 18.4000 -45.88%
2007 229.9124 271.5000 457.2000 32.0000 34.0000 -79.64%
2006 378.3625 406.0000 539.0000 152.0000 167.0000 -60.71%
2005 47.9270 20.0000 511.0000 13.0000 425.0000 2025.00%
2004 25.6667 40.0000 40.0000 20.0000 20.0000 -50.00%
2003 21.0833 11.0000 51.0000 11.0000 40.0000 263.64%
2002 23.4921 23.0000 38.0000 11.0000 11.0000 -52.17%
2001 24.8557 19.0000 40.0000 15.0000 23.0000 22.99%
2000 32.0927 88.0000 94.0000 6.0000 18.7000 -78.63%
1999 95.3274 188.0000 263.0000 6.0000 87.5000 -61.11%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.035B $0.055B
Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx(R). Protalix's unique expression system presents a proprietary method for developing recombinant proteins in a cost-effective, industrial-scale manner. Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved for marketing by the U.S. Food and Drug Administration (FDA) in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.941B 13.37
Gilead Sciences (GILD) United States $91.719B 11.86
CSL (CSLLY) Australia $79.295B 0.00
Vertex Pharmaceuticals (VRTX) United States $56.324B 51.12
Biogen (BIIB) United States $51.654B 8.82
Regeneron Pharmaceuticals (REGN) United States $49.455B 20.95
Illumina (ILMN) United States $39.550B 40.89
Seattle Genetics (SGEN) United States $18.823B 0.00
Alexion Pharmaceuticals (ALXN) United States $18.600B 8.65
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $14.949B 32.07
BioMarin Pharmaceutical (BMRN) United States $14.306B 611.61
Genmab (GNMSF) Denmark $12.862B 41.37
BioNTech SE (BNTX) Germany $12.444B 0.00
Alnylam Pharmaceuticals (ALNY) United States $11.782B 0.00
Galapagos (GLPG) Belgium $11.779B 25.73
Bio-Rad Laboratories (BIO.B) United States $9.935B 46.43
Moderna (MRNA) United States $9.887B 0.00
QIAGEN (QGEN) Netherlands $9.213B 28.09
Exact Sciences (EXAS) United States $8.567B 0.00
BeiGene (BGNE) Cayman Islands $8.176B 0.00
Sarepta Therapeutics (SRPT) United States $7.345B 0.00
Bio-Techne Corp (TECH) United States $7.072B 48.40
Guardant Health (GH) United States $6.398B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.032B 0.00
Ascendis Pharma (ASND) Denmark $5.414B 0.00
Exelixis (EXEL) United States $5.262B 16.89
Horizon Therapeutics Public (HZNP) Ireland $5.235B 13.83
Reata Pharmaceuticals (RETA) United States $4.984B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.980B 0.00
Repligen (RGEN) United States $4.820B 88.14
Amarin (AMRN) Ireland $4.730B 0.00
Acceleron Pharma (XLRN) United States $4.643B 0.00
China Biologic Products (CBPO) China $4.279B 25.40
Vir Biotechnology (VIR) United States $3.762B 0.00
MorphoSys AG (MOR) Germany $3.364B 0.00
Mirati Therapeutics (MRTX) United States $3.318B 0.00
Adaptive Biotechnologies (ADPT) United States $3.206B 0.00
Blueprint Medicines (BPMC) United States $3.140B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.130B 0.00
Global Blood Therapeutics (GBT) United States $3.110B 0.00
Zai Lab (ZLAB) China $2.961B 0.00
Immunomedics (IMMU) United States $2.747B 0.00
NeoGenomics (NEO) United States $2.695B 116.86
Emergent Biosolutions (EBS) United States $2.663B 18.49
Bluebird Bio (BLUE) United States $2.657B 0.00
Genmab (GMAB) Denmark $2.588B 10.15
CRISPR Therapeutics AG (CRSP) Switzerland $2.545B 43.11
MyoKardia (MYOK) United States $2.488B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.452B 0.00
Halozyme Therapeutics (HALO) United States $2.416B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.329B 0.00
Amicus Therapeutics (FOLD) United States $2.300B 0.00
Alkermes (ALKS) Ireland $2.272B 180.00
Arena Pharmaceuticals (ARNA) United States $2.238B 5.83
RA PHARMCTL INC (RARX) United States $2.220B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.138B 0.00
Denali Therapeutics (DNLI) United States $1.995B 0.00
UniQure (QURE) Netherlands $1.959B 0.00
Epizyme (EPZM) United States $1.792B 0.00
Alector (ALEC) United States $1.787B 0.00
Viela Bio (VIE) United States $1.769B 0.00
Fate Therapeutics (FATE) United States $1.684B 0.00
Principia Biopharma (PRNB) United States $1.673B 0.00
Eidos Therapeutics (EIDX) United States $1.618B 0.00
Insmed (INSM) United States $1.541B 0.00
Arvinas (ARVN) United States $1.538B 0.00
Zymeworks (ZYME) Canada $1.470B 0.00
Akcea Therapeutics (AKCA) United States $1.345B 28.93
Dicerna Pharmaceuticals (DRNA) United States $1.263B 0.00
REGENXBIO (RGNX) United States $1.258B 0.00
Inovio Pharmaceuticals (INO) United States $1.213B 0.00
Coherus BioSciences (CHRS) United States $1.148B 13.66
Ligand Pharmaceuticals (LGND) United States $1.102B 34.25
Editas Medicine (EDIT) United States $1.095B 0.00
Twist Bioscience (TWST) United States $1.063B 0.00
Zealand Pharma (ZEAL) Denmark $1.054B 0.00
Myriad Genetics (MYGN) United States $1.048B 18.50
NextCure (NXTC) United States $1.007B 0.00
PHARMA MAR SA (PHMMF) Spain $0.983B 0.00
Adverum Biotechnologies (ADVM) United States $0.911B 0.00
Revance Therapeutics (RVNC) United States $0.887B 0.00
NGM Biopharmaceuticals (NGM) United States $0.886B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.877B 0.00
Sangamo Therapeutics (SGMO) United States $0.737B 0.00
Cytokineticsorporated (CYTK) United States $0.699B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.680B 0.00
Novavax (NVAX) United States $0.672B 0.00
Kadmon Holdings (KDMN) United States $0.637B 0.00
Athenex (ATNX) United States $0.615B 0.00
Pharming Group (PHGUF) Netherlands $0.613B 0.00
Frequency Therapeutics (FREQ) United States $0.609B 0.00
Codexis (CDXS) United States $0.607B 0.00
Retrophin (RTRX) United States $0.594B 0.00
Cara Therapeutics (CARA) United States $0.589B 0.00
Intellia Therapeutics (NTLA) United States $0.583B 0.00
Arcus Biosciences (RCUS) United States $0.582B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.582B 0.00
Bellus Health (BLU) Canada $0.554B 0.00
GENFIT S.A (GNFT) France $0.552B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.537B 0.00
Intrexon (PGEN) United States $0.533B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.528B 0.00
Clovis Oncology (CLVS) United States $0.524B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.491B 4.32
Compugen (CGEN) Israel $0.491B 0.00
Castle Biosciences (CSTL) United States $0.486B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
ANI Pharmaceuticals (ANIP) United States $0.457B 8.24
Mesoblast (MESO) Australia $0.435B 0.00
DBV Technologies S.A (DBVT) France $0.434B 0.00
MeiraGTx Holdings (MGTX) United States $0.429B 0.00
AC Immune SA (ACIU) Switzerland $0.429B 9.92
Morphic Holding (MORF) United States $0.427B 0.00
Vericel (VCEL) United States $0.422B 62.60
Heska (HSKA) United States $0.419B 0.00
Anika Therapeutics (ANIK) United States $0.415B 14.29
Aquinox Pharmaceuticals (NLTX) United States $0.405B 0.00
MiMedx (MDXG) United States $0.403B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
Scholar Rock Holding (SRRK) United States $0.400B 0.00
Verastem (VSTM) United States $0.400B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.398B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.385B 0.00
Prothena (PRTA) Ireland $0.383B 0.00
AnaptysBio (ANAB) United States $0.382B 0.00
Agenus (AGEN) United States $0.380B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.371B 0.00
UROGEN PHARMA (URGN) United States $0.370B 0.00
Cellectis S.A (CLLS) France $0.365B 0.00
Merus (MRUS) Netherlands $0.360B 0.00
Cue Biopharma (CUE) United States $0.352B 0.00
BioDelivery Sciences (BDSI) United States $0.340B 39.22
Puma Biotechnology (PBYI) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.336B 10.07
Sorrento Therapeutics (SRNE) United States $0.328B 0.00
Athersys (ATHX) United States $0.322B 0.00
WAVE Life Sciences (WVE) Singapore $0.319B 0.00
Precision BioSciences (DTIL) United States $0.318B 0.00
NantKwest (NK) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.297B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.292B 0.00
CytomX Therapeutics (CTMX) United States $0.289B 0.00
Mersana Therapeutics (MRSN) United States $0.287B 0.00
Kala Pharmaceuticals (KALA) United States $0.285B 0.00
ADMA Biologics Inc (ADMA) United States $0.265B 0.00
Avid Bioservices (CDMO) United States $0.264B 0.00
Albireo Pharma (ALBO) United States $0.248B 0.00
Kamada (KMDA) Israel $0.244B 10.17
Seres Therapeutics (MCRB) United States $0.244B 0.00
Alcobra (ARCT) United States $0.239B 0.00
Sutro Biopharma (STRO) United States $0.226B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.226B 0.00
MannKind (MNKD) United States $0.225B 0.00
Stemline Therapeutics (STML) United States $0.222B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.218B 0.00
Syros Pharmaceuticals (SYRS) United States $0.218B 0.00
Geron (GERN) United States $0.214B 0.00
Aduro Biotech (ADRO) United States $0.206B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.204B 0.00
Gritstone Oncology (GRTS) United States $0.202B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.193B 1.73
XOMA (XOMA) United States $0.185B 0.00
Selecta Biosciences (SELB) United States $0.183B 0.00
ChromaDex (CDXC) United States $0.176B 0.00
OSMOTICA PHARM (OSMT) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.175B 0.00
HOOKIPA Pharma (HOOK) United States $0.173B 0.00
IVERIC Bio (ISEE) United States $0.172B 0.00
Abeona Therapeutics (ABEO) United States $0.172B 0.00
Starpharma Holdings (SPHRY) Australia $0.168B 0.00
VBI Vaccines (VBIV) United States $0.166B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Prometic Life Sciences (LMNL) Canada $0.160B 0.00
Kindred Biosciences (KIN) United States $0.160B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.158B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
POXEL SA FRANCE (PXXLF) France $0.145B 0.00
Windtree Therapeutics (WINT) United States $0.144B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.137B 0.00
Cerecor (CERC) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.135B 0.00
Fortress Biotech (FBIO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.132B 0.00
VTv Therapeutics (VTVT) United States $0.132B 0.00
Dyadic (DYAI) United States $0.122B 0.00
Antibe Therapeutics (ATBPF) Canada $0.121B 0.00
Affimed (AFMD) Germany $0.119B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.118B 0.00
Theratechnologies (THTX) Canada $0.118B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Exicure (XCUR) United States $0.115B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.110B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.102B 0.00
Strongbridge Biopharma (SBBP) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aptinyx (APTX) United States $0.095B 0.00
TELA Bio (TELA) United States $0.091B 0.00
OvaScience (MLND) United States $0.088B 0.00
Checkpoint Therapeutics (CKPT) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.086B 0.00
Five Prime Therapeutics (FPRX) United States $0.085B 0.00
Cyclerion Therapeutics (CYCN) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.083B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Eton Pharmaceuticals (ETON) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.075B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
Menlo Therapeutics (MNLO) United States $0.070B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.069B 0.00
Proteostasis Therapeutics (PTI) United States $0.067B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Adocia (ADOCY) France $0.066B 0.00
Emmaus Life Sciences (EMMA) United States $0.064B 0.00
SESEN BIO, INC (SESN) United States $0.062B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Orgenesis (ORGS) United States $0.061B 3.55
Synlogic (SYBX) United States $0.060B 0.00
AquaBounty Technologies (AQB) United States $0.059B 0.00
Catalyst Biosciences (CBIO) United States $0.057B 0.00
Trevena (TRVN) United States $0.056B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Acorda Therapeutics (ACOR) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.043B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Soligenix (SNGX) United States $0.038B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.036B 0.00
Lumos Pharma (LUMO) United States $0.036B 0.00
Advaxis (ADXS) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.034B 0.00
TOCAGEN INC (TOCA) United States $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.028B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Celsion (CLSN) United States $0.020B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.014B 0.00
AEterna Zentaris (AEZS) United States $0.013B 0.00
Aptevo Therapeutics (APVO) United States $0.013B 0.00
ATyr Pharma (LIFE) United States $0.013B 0.00
TrovaGene (TROV) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00